Selective Oxidation of Alpha-Tocotrienol Using Sequential Iron(III) Addition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for synthesizing alpha-tocotrienol quinone often result in higher concentrations of side-products due to the presence of non-alpha tocotrienols, leading to impurities in the final product, and require higher stoichiometric ratios of oxidizing agents, which complicates the purification process.
Innovation Solution
A method involving the selective oxidation of alpha-tocotrienol using an iron(III) salt oxidizing agent in a biphasic solution with a stoichiometric ratio of at least 4:1, where the oxidizing agent is added in sequential portions to preferentially oxidize alpha-tocotrienol over non-alpha tocotrienols, minimizing the formation of undesirable quinones and achieving high purity of alpha-tocotrienol quinone.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional oxidation methods are used with commercial R,R,R-alpha-tocopheryl acetate containing non-alpha tocopherols, then the synthesis can proceed with standard conditions, but higher concentrations of side-products are formed and purification becomes more difficult
Solution Approach 1:
The patent changes the stoichiometric ratio parameter by using at least 4 equivalents of iron(III) salt per equivalent of alpha-tocotrienol, which is higher than traditional methods. This parameter change enables selective oxidation of alpha-tocotrienol over non-alpha tocotrienols, achieving greater than 99% purity while maintaining ease of manufacture with simple filtration and concentration steps.
2Reliability
If higher stoichiometric ratios of oxidizing agents are used to ensure complete oxidation, then oxidation completeness improves, but the complexity of the purification process increases
Solution Approach 1:
The patent employs sequential additions of the iron(III) salt oxidizing agent in multiple portions, allowing the reaction mixture to settle between additions. This self-service approach enables complete oxidation (greater than 99% conversion) while keeping the purification process simple, as the settled mixture can be directly filtered and concentrated without complex purification steps.
3Manufacturing precision
If sequential additions of oxidizing agent are used, then selective oxidation of alpha-tocotrienol is achieved, but the reaction time and number of steps increase
Solution Approach 1:
The patent uses periodic action by adding the iron(III) salt oxidizing agent in sequential portions rather than all at once. Each portion is added, allowed to react and settle, then the next portion is added. This periodic approach achieves high selectivity for alpha-tocotrienol oxidation while managing reaction time efficiently through controlled, staged additions rather than continuous monitoring.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the amount of non-alpha tocotrienol quinones in the final product, achieving purities greater than 99% alpha-tocotrienol quinone with minimal side-products, enhancing the effectiveness and efficiency of the synthesis process.
Implementation Method 1
selectively oxidizing alpha-tocotrienol in the presence of non-alpha tocotrienols, with a metal salt oxidizing agent to form alpha-tocotrienol quinone
Implementation Method 2
oxidation of alpha-tocotrienol with ferric chloride
Data Source
AI summary
A method of producing alpha-tocotrienol quinone or a stereoisomer thereof, the method comprising selective opening of alpha-tocotrienol chroman to alpha-tocotrienol quinone in the presence of non-alpha tocotrienol chromans by oxidizing alpha-tocotrienol with a metal salt oxidizing agent, wherein the stoichiometric ratio of metal salt oxidizing agent/alpha-tocotrienol is at least 4: 1 and wherein said metal oxidizing agent is added in sequential additions, in order to reduce oxidation of any amounts of non-alpha tocotrienol chromans that might have been present in the starting alpha-tocotrienol chroman material. This process uses conditions favoring oxidation rates of the alpha tocotrienol chroman vs. the non-alpha tocotrienol chromans.